Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Substance Abuse Treatment, Prevention, and Policy
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2016

Open Access 01-12-2016 | Review

A narrative review of alcohol consumption as a risk factor for global burden of disease

Authors: Jürgen Rehm, Sameer Imtiaz

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2016

Login to get access

Abstract

Since the original Comparative Risk Assessment (CRA) for alcohol consumption as part of the Global Burden of Disease Study for 1990, there had been regular updates of CRAs for alcohol from the World Health Organization and/or the Institute for Health Metrics and Evaluation. These studies have become more and more refined with respect to establishing causality between dimensions of alcohol consumption and different disease and mortality (cause of death) outcomes, refining risk relations, and improving the methodology for estimating exposure and alcohol-attributable burden. The present review will give an overview on the main results of the CRAs with respect to alcohol consumption as a risk factor, sketch out new trends and developments, and draw implications for future research and policy.
Literature
1.
Murray CJL, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. WHO Bulletin. 1994;72:496–509.
2.
World Bank. World Development Report 1993 -- Investing in Health. New York, ISBN 0-19-520890-0: 1993.
3.
4.
Murray CJL. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Org. 1994;72:429–45.PubMedPubMedCentral
5.
Murray CJL, Salomon J, Mathers C, Lopez A. Summary measures of population health: Concepts, ethics, measurement and applications. Geneva: World Health Organization; 2002.
6.
Lopez AD. Cause of death in industrial and developing countries: estimates for 1985-1990. In: Jamison DT, Mosley WH, Measham AR, Bobadilla JL, editors. Disease Control Priorities in Developing Countries. Oxford: Oxford University Press (for the World Bank); 1993. p. 35–50.
7.
Ezzati M, Lopez A, Rodgers A, Murray CJL. Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization; 2004.
8.
9.
World Health Organization. Global status report on alcohol and health. Geneva: World Health Organization; 2014.
10.
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.PubMedPubMedCentralCrossRef
11.
Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287–323.PubMedCrossRef
12.
Murray CJL, Lopez A. Quantifying the burden of disease and injury attributable to ten major risk factors. In: Murray CJL, Lopez AD, editors. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Boston: Harvard School of Public Health on Behalf of the World Health Organization and the World Bank; 1996. p. 295–324.
13.
Anderson P, Braddick F, Conrod P, Gual A, Hellman M, Matrai S, et al. The New Governance of Addictive Substances and Behaviours. Oxford: Oxford University Press; 2016.
14.
Chisholm D, Rehm J, van Ommeren M, Monteiro M. Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. J Stud Alcohol. 2004;65:782–93.PubMedCrossRef
15.
Chisholm D, Doran C, Shibuya K, Rehm J. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use. Drug Alcohol Rev. 2006;25:553–65.PubMedCrossRef
16.
Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, et al. Alcohol Use. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization; 2004. p. 959–1109.
17.
Rehm J, Borges G, Gmel G, Graham K, Grant B, Parry C, et al. The comparative risk assessment for alcohol as part of the Global Burden of Disease 2010 study: What changed from the last study? Int J Alcohol Drug Res. 2013;2:1–5.CrossRef
18.
19.
Shield KD, Rylett M, Rehm J. Public health gains and missed opportunities. Trends in alcohol consumption and attributable mortality in the WHO European Region, 1990-2014: A Report to the WHO European Region. Toronto, Canada: Centre for Addiction and Mental Health; ISBN - 978-1-77114-367-7.  2016
20.
Shield KD, Rylett M, Rehm J. Public health successes and missed opportunities. Trends in alcohol consumption and attributable mortality in the WHO European Region, 1990-2014. Copenhagen: WHO European Region; 2016.
21.
Shield KD, Popova S, Rehm J. The burden of disease and injury caused by alcohol. Reference Module in Biomedical Sciences. Elsevier online via science direct. doi: 10.​1016/​B978-0-12-801238-3.​03188-3. Reference Module in Biomedical Sciences, Elsevier online via science direct. 2015.
22.
23.
Murray CJ, Lozano R, Flaxman AD, Serina P, Phillips D, Stewart A, et al. Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med. 2014;12:5.PubMedPubMedCentralCrossRef
24.
Rehm J, Mathers C. Global comparative risk assessment - what level of detail can be achieved? Lancet. 2009;374:477.CrossRef
25.
Goerdt A, Koplan J, Robine J, Thuriaux M, van Ginneken J. Non-fatal health outcomes: Concepts, instruments and indicators. In: Murray C, Lopez A, editors. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Boston: Harvard School of Public Health on behalf of the World Health Organization and the World Bank; 1996. p. 99–117.
26.
Flaxman AD, Vos T, Murray CJL. An Integrative Metaregression Framework for Descriptive Epidemiology. Washington: University of Washington Press; 2015.
27.
Rehm J, Frick U. Valuation of health states in the U.S. study to establish disability weights: lessons from the literature. Int J Methods Psychiatr Res. 2010;19:18–33.PubMedPubMedCentralCrossRef
28.
29.
30.
Kovacs SD, Mullholland K, Bosch J, Campbell H, Forouzanfar MH, Khalil I, et al. Deconstructing the differences: a comparison of GBD 2010 and CHERG's approach to estimating the mortality burden of diarrhea, pneumonia, and their etiologies. BMC Infectious Disease. 2015;16:16.CrossRef
31.
Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380:2129–43.PubMedCrossRef
32.
Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, et al. Disability weights for the global burden of disease 2013 study. Lancet Global Health. 2015;3:e712–23.PubMedCrossRef
33.
Burstein R, Fleming T, Haagsma J, Salomon JA, Vos T, Murray CJ. Estimating distributions of health state severity for the global burden of disease study. Popul Health Metr. 2015;18:31.CrossRef
34.
Rehm J. How should prevalence of alcohol use disorders be assessed globally? Int J Methods Psychiatr Res. 2016;25:79–85.PubMedCrossRef
35.
36.
37.
Irving HM, Samokhvalov A, Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP. 2009;10:387–92.PubMedPubMedCentral
38.
Samokhvalov AV, Rehm J, Roerecke M. Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic review and a series of meta-analyses. EBioMedicine. 2015;2:1996–2002.PubMedPubMedCentralCrossRef
39.
Rehm J, Dawson D, Frick U, Gmel G, Roerecke M, Shield KD, et al. Burden of disease associated with alcohol use disorders in the United States. Alcohol Clin Exp Res. 2014;38:1068–77.PubMedPubMedCentralCrossRef
40.
41.
Popova S, Lange S, Shield KD, Mihic A, Chudley AE, Mukherjee RAS, et al. Co-morbidity of fetal alcohol spectrum disorder: a systematic literature review and metaanalysis. Lancet. 2016;387:978–87.PubMedCrossRef
42.
Rehm J, Shield K. Alcohol consumption. In: Steward BW, Wild CP, editors. World Cancer Report. Lyon: International Agency for Research on Cancer; 2014. p. 97–107.
43.
International Agency for Research on Cancer. Alcohol Drinking. Lyon: International Agency for Research on Cancer; 1988.
44.
International Agency for Research on Cancer: IARC Monographs on the evaluation of carcinogenic risks to humans: Alcohol consumption and ethyl carbamate. In., vol. 96. Lyon, France: International Agency for Research on Cancer; 2010.
45.
International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans 100E Personal Habits and Indoor Combustions. Lyon: International Agency for Research on Cancer; 2012.
46.
Leoncini E, Carioli G, La Vecchia C, Boccia S, Rindi G. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol. 2016;27:68–81.PubMedCrossRef
47.
Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112:580–93.PubMedCrossRef
48.
Rush B. An inquiry into the effects of ardent spirits upon the human body and mind: With an account of the means of preventing, and of the remedies for curing them. 8th edition. Reprint. Richardson: Exeter, N.H; 1785.
49.
Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
50.
Parry C, Rehm J, Poznyak V, Room R. Alcohol and infectious diseases: an overlooked causal linkage? Addiction. 2009;104:331–2.PubMedCrossRef
51.
Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry CD, Lönnroth K, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9:450.PubMedPubMedCentralCrossRef
52.
Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for pneumonia: systematic review and meta-analysis. Epidemiol Infect. 2010;138:1789–95.PubMedCrossRef
53.
Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55:159–66.PubMedCrossRef
54.
Parry CDH, Rehm J, Morojele NK. Is there a causal relationship between alcohol and HIV? African J Drug Alcohol Studies. 2010;9:81–92.
55.
Fisher JC, Bang H, Kapiga SH. The association between HIV infection and alcohol use: a systematic review and meta-analysis of African studies. Sex Transm Dis. 2007;34:856–63.PubMedCrossRef
56.
Gmel G, Shield K, Rehm J. Developing a methodology to derive alcohol-attributable fractions for HIV/AIDS mortality based on alcohol's impact on adherence to antiretroviral medication. Popul Health Metr. 2011;9:5.PubMedPubMedCentralCrossRef
57.
Rehm J, Shield KD, Joharchi N, Shuper PA. Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction. 2012;107:51–9.PubMedCrossRef
58.
Scott-Sheldon LA, Carey KB, Cunningham K, Johnson BT, Carey MP. Alcohol use predicts sexual decision-making: a systematic review and meta-analysis of the experimental literature. AIDS Behav. 2015;Suppl 1:S19–39.
59.
Ferreira-Borges C, Rehm J, Dias S, Babor T, Parry CD. The impact of alcohol consumption on African people in 2012: an analysis of burden of disease. Trop Med Int Health. 2016;21:52–60.PubMedCrossRef
60.
Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997;54:313–21.PubMedCrossRef
61.
Regier D, Farmer M, Rae D, Locke B, Keith S, Judd L, et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiological Catchment Area (ECA) Study. JAMA. 1990;264:2511–8.PubMedCrossRef
62.
Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol. 1988;49:219–24.PubMedCrossRef
63.
Rehm J, Anderson P, Gual A, Kraus L, Marmet S, Room R, et al. The tangible common denominator of substance use disorders: a reply to commentaries to Rehm et al. (2013). Alcohol Alcohol. 2014;49:118–22.PubMedCrossRef
64.
Rehm J, Marmet S, Anderson P, Gual A, Kraus L, Nutt DJ, et al. Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol. 2013;48:633–40.PubMedCrossRef
65.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th edition). Philadelphia: American Psychiatric Association; 2013.CrossRef
66.
World Health Organization. ICD-10 Classification of mental and behavioural disorders: with glossary and diagnostic criteria for research. New York: Churchill Livingstone; 1994.
67.
68.
Foulds JA, Adamson SJ, Boden JM, Williman JA, Mulder RT. Depression in patients with alcohol use disorders: Systematic review and meta-analysis of outcomes for independent and substance-induced disorders. J Affect Disord. 2015;1:47–59.CrossRef
69.
Samokhvalov AV, Irving H, Mohapatra S, Rehm J. Alcohol consumption, unprovoked seizures and epilepsy: a systematic review and meta-analysis. Epilepsia. 2010;51:1177–84.PubMedCrossRef
70.
Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, et al. Alcohol as a risk factor for liver cirrhosis - a systematic review and meta-analysis. Drug Alcohol Rev. 2010;29:437–45.PubMedCrossRef
71.
Baliunas D, Taylor B, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a risk factor for type 2 diabetes - A systematic review and meta-analysis. Diabetes Care. 2009;32:2123–32.PubMedPubMedCentralCrossRef
72.
Roerecke M, Rehm J. Alcohol intake revisited: risks and benefits. Curr Atheroscler Rep. 2012;14:556–62.PubMedCrossRef
73.
Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009;104:1981–90.PubMedCrossRef
74.
Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014;12:182.PubMedPubMedCentralCrossRef
75.
Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, et al. Alcohol consumption and the risk of morbidity and mortality from different stroke types - a systematic review and meta-analysis. BMC Public Health. 2010;10:258.PubMedPubMedCentralCrossRef
76.
Samokhvalov AV, Irving HM, Rehm J. Alcohol as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiov Prev R. 2010;17:706–12.CrossRef
77.
Cherpitel C, Ye Y, Bond J, Borges G, Autonoma M, Monteiro M, et al. Alcohol attributable fraction for injury morbidity from the dose-response relationship of acute alcohol consumption: emergency department data from 18 countries. Addiction. 2015;110:1724–32.PubMedCrossRef
78.
Rehm J. Commentary on Cherpitel et al. (2015): improving global estimates of alcohol-attributable injury. Addiction. 2015;110:1733–4.CrossRef
79.
Gell L, Ally A, Buykx P, Hope A, Meier P. Alcohol's harm to others: An Insitute of Alcohol Studies report. United Kingdom: Institute of Alcohol Studies; 2015.
80.
Laslett AM, Catalano P, Chikritzhs T, Dale C, Doran C, Ferris J, et al. The range and magnitude of alcohol's harm to others. Fitzroy: Turning Point Alcohol & Drug Centre; 2010.
81.
Shield KD, Rylett MJ, Gmel G, Rehm J. Trends in alcohol consumption and alcohol-attributable mortality in the EU in 2010. In: World Health Organization Regional Office for Europe, editor. Status report on alcohol and health in 35 European countries. Copenhagen: WHO Regional Office for Europe; 2013.
82.
Patra J, Bakker R, Irving H, Jaddoe VWV, Malini S, Rehm J. Dose-response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)-a systematic review and meta-analyses. Int J Gynaecol Obstet. 2011;118:1411–21.CrossRef
83.
Shield KD, Parry C, Rehm J. Chronic diseases and conditions related to alcohol use. Alcohol Res. 2013;35:155–71.PubMed
84.
Shield K, Rehm J. Russia-specific relative risks and their effects on the estimated alcohol-attributable burden of disease. BMC Public Health. 2015;15:482.PubMedPubMedCentralCrossRef
85.
Shield KD, Soerjomataram I, Rehm J. Alcohol use and breast cancer: a critical review. Alcohol Clin Exp Res. 2016;40:1166–81.PubMedCrossRef
86.
Rehm J. Light or moderate drinking is linked to alcohol related cancers, including breast cancer. BMJ. 2015;351:h4400.PubMedCrossRef
87.
Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38:613–9.PubMedCrossRef
88.
Rehm J, Baliunas D, Borges GL, Graham K, Irving HM, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease - An overview. Addiction. 2010;105:817–43.PubMedPubMedCentralCrossRef
89.
Rehm J, Shield KD, Roerecke M, Gmel G. Modelling the impact of alcohol consumption on cardiovascular disease mortality for comparative risk assessments: an overview. BMC Public Health. 2016;16:363.PubMedPubMedCentralCrossRef
90.
Roerecke M, Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol. 2010;171:633–44.PubMedCrossRef
91.
Mostofsky E, van der Bom JG, Mukamal KJ, Maclure M, Tofler M, Tofler GH, et al. Risk of myocardial infarction immediately after alcohol consumption. Epidemiology. 2015;26:143–50.PubMedPubMedCentralCrossRef
92.
Marmot MG, Shipley MJ, Rose G, Thomas B. Alcohol and mortality: a U-shaped curve. Lancet. 1981;317:580–3.CrossRef
93.
European Association for the Study of the Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012;57:j399–420.CrossRef
94.
Lachenmeier DW, Kanteres F, Rehm J. Epidemiology-based risk assessment using the benchmark dose/margin of exposure approach: the example of ethanol and liver cirrhosis. Int J Epidemiol. 2011;40:210–8.PubMedCrossRef
95.
Rehm J, Roerecke M. Patterns of drinking and liver cirrhosis - what do we know and where do we go? J Hepatol. 2015;62:1061–7.CrossRef
96.
Sindelar H, Barnett N, Spirito A. Adolescent alcohol use and injury. A summary and critical review of the literature. Minerva Pediatr. 2004;56:291–309.PubMed
97.
Rehm J, Gmel G, Sempos C, Trevisan M. Alcohol-related mortality and morbidity. Alcohol Res Health. 2003;27:39–51.PubMed
98.
Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet. 2009;373:2201–14.PubMedPubMedCentralCrossRef
99.
Zaridze D, Lewington S, Boroda A, Scélo G, Karpov R, Lazarev A, et al. Alcohol and mortality in Russia: prospective observational study of 151,000 adults. Lancet. 2014;383:1465-73.
100.
Rehm J. What can we learn from Russia about alcohol epidemiology and alcohol policy? Lancet. 2014;383:1440–2.PubMedCrossRef
101.
Room R, Jernigan D, Carlini BH, Gmel G, Gureje O, Mäkelä K, et al. El alcohol y los países en desarrollo. Una perspectiva de salud pública. Mexico: Organización Panamericana de la Salud & Fondo de Cultura Económica; 2013.
102.
Rehm J, Monteiro M, Room R, Gmel G, Jernigan D, Frick U, et al. Steps towards constructing a global comparative risk analysis for alcohol consumption: Determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum, and dealing with different consequences. Eur Addict Res. 2001;7:138–47.PubMedCrossRef
103.
Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med. 2009;6:258–63.CrossRef
104.
Roerecke M, Shield KD, Higuchi S, Yoshimura A, Larsen E, Rehm MX, et al. Estimates of alcohol-related oesophageal cancer burden in Japan: systematic review and meta-analyses. Bull World Health Org. 2015;93:329–338c.PubMedPubMedCentralCrossRef
105.
Murray CJL, Ezzati M, Lopez AD, Rodgers A, Vander HS. Comparative quantification of health risks: conceptual framework and methodological issues. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative Quantification of Health Risks: Global and regional Burden of Disease attributable to selected major risk factors. Geneva: World Health Organization; 2004. p. 1–38.
106.
Vander Hoorn S, Ezzati M, Rodgers A, Lopez AD, Murray CJL. Estimating attributable burden of disease from exposure and hazard data. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva: World Health Organization; 2004. p. 2129–40.
107.
Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics. 1976;32:829–49.PubMedCrossRef
108.
Walter SD. Prevention of multifactorial disease. Am J Epidemiol. 1980;112:409–16.PubMed
109.
Murray CJL, Lopez A. On the comparable quantification of health risks: lessons from the global burden of disease study. Epidemiology. 1999;10:594–605.PubMedCrossRef
110.
Rehm J, Kehoe T, Gmel G, Stinson F, Grant B, Gmel G. Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the example of the US. Popul Health Metr. 2010;8:3.PubMedPubMedCentralCrossRef
111.
Rehm J, Klotsche J, Patra J. Comparative quantification of alcohol exposure as risk factor for global burden of disease. Int J Methods Psychiatr Res. 2007;16:66–76.PubMedCrossRef
112.
Kehoe T, Gmel Jr G, Shield K, Gmel Sr G, Rehm J. Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms. Popul Health Metr. 2012;10:6.PubMedPubMedCentralCrossRef
113.
Gmel G, Rehm J. Measuring alcohol consumption. Contemp Drug Probl. 2004;31:467–540.
114.
Poznyak V, Fleischmann A, Rekve D, Rylett M, Rehm J, Gmel G. The World Health Organization’s Global monitoring system on alcohol and health. Alcohol Res. 2013;35:244–9.PubMed
115.
Midanik LT. The validity of self-reported alcohol consumption and alcohol problems: a literature review. Br J Addict. 1982;77:357–82.PubMedCrossRef
116.
Midanik L. Validity of self-reported alcohol use: a literature review and assessment. Br J Addict. 1988;83:1019–29.PubMedCrossRef
117.
Shield K, Kehoe T, Taylor B, Patra J, Rehm J. Alcohol-attributable burden of disease and injury in Canada, 2004. Int J Public Health. 2012;57:391–401.PubMedCrossRef
118.
Ramstedt M. How much alcohol do you buy? A comparison of self-reported alcohol purchases with actual sales. Addiction. 2010;105:649–54.PubMedCrossRef
119.
Ministry of Health. Alcohol Use in New Zealand: Key results of the 2007/08 New Zealand Alcohol and Drug Use Survey. Wellington: Ministry of Health; 2009.
120.
121.
Willett W. Nutritional epidemiology. Oxford: Oxford University Press; 2012.CrossRef
122.
Giovannucci E, Colditz G, Stampfer MJ, Rimm EB, Litin L, Sampson L, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol. 1991;133:810–7.PubMed
123.
Shield K, Rehm J. Difficulties with telephone-based surveys on alcohol in high-income countries: the Canadian example. Int J Methods Psychiatr Res. 2012;21:17–28.PubMedPubMedCentralCrossRef
124.
Rey G, Boniol M, Jougla E. Estimating the number of alcohol-attributable deaths: methodological issues and illustration with French data for 2006. Addiction. 2010;105:1018–29.PubMedCrossRef
125.
Rehm J. Commentary on Rey et al. (2010): How to improve estimates on alcohol-attributable burden? Addiction. 2010;105:1030–1.PubMedCrossRef
126.
Holmes J, Meier PS, Booth A, Guo Y, Brennan A. The temporal relationship between per capita alcohol consumption and harm: a systematic review of time lag specifications in aggregate time series analyses. Drug Alcohol Depend. 2012;123:7–14.PubMedCrossRef
127.
Rehm J. Alcohol consumption and mortality. What do we know and where should we go? Addiction. 2000;95:989–95.PubMedCrossRef
128.
Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, Bonita R, et al. Contribution of six risk factors to achieving the “25 × 25” NCD mortality reduction target. Lancet. 2014;384:427–37.PubMedCrossRef
129.
Kontis V, Mathers CD, Bonita R, Stevens GA, Rehm J, Shield KD, et al. Regional contributions of six preventable risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study. Lancet Global Health. 2015;3:e746–57.PubMedCrossRef
130.
Gmel G, Kuntsche E, Rehm J. Risky single occasion drinking: bingeing is not bingeing. Addiction. 2011;106:1037–45.PubMedCrossRef
131.
Gmel G, Kuntsche E, Rehm J. Risky single occasion drinking research: the four stages of enlightenment. Addiction. 2011;106:1050–1.CrossRef
132.
Praud D, Rota M, Rehm J, Shield K, Zatonski W, Hashibe M, et al. Cancer incidence and mortality attributable to alcohol consumption. Int J Cancer. 2016;138:1380–7.PubMedCrossRef
133.
Gmel G, Rehm J. Harmful alcohol use. Alcohol Res Health. 2003;27:52–62.PubMed
134.
Roberts H, Meddings D. Violence and unintentional injury: equity and social determinants. In: Blas E, Kurup AS, editors. Equity, social determinants and public health programmes. Geneva: World Health Organization; 2010. p. 243–59.
135.
Room R, Ferris J, Laslett AM, Livingston M, Mugavin J, Wilkinson C. The drinker's effect on the social environment: a conceptual framework for studying alcohol's harmto others. Int J Environ Res Public Health. 2010;7:1855–71.PubMedPubMedCentralCrossRef
136.
World Health Organization. Global status report on road safety 2015. Geneva: World Health Organization; 2015.
137.
Lange S, Probst C, Heer N, Roerecke M, Rehm J, Monteiro MG et al. Actual and predicted prevalence of alcohol consumption during pregnancy in Latin America and the Caribbean: systematic literature review and meta-analysis. Revista Panamericana de Salud Pública/Pan American Journal of Public Health. 2016; epub ahead of print
138.
Popova S, Lange S, Probst C, Gmel G, Rehm J. Estimation of national, regional and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Toronto: Centre for Addiction and Mental Health; 2016.
139.
Kamerstuk - Eerste Kamer der Staten-General. 33 799 Wijziging van het Wetboek van Strafvordering in verband met de introductie van de bevoegdheid tot het bevelen van een middelenonderzoek bij geweldplegers en enige daarmee samenhangende wijzigingen van de Wegenverkeerswet 1994 [33 799 Amendment of the Code of Criminal Procedure in connection with the introduction of the power to recommend an agent study of violent offenders and any related amendments to the Road Traffic Act 1994]. Netherlands: Verheid; 2016.
140.
Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht N, Graham K, et al. Alcohol: No ordinary commodity. Research and public policy. 2nd edition. Oxford and London: Oxford University Press; 2010.CrossRef
141.
Anderson P, Chisholm D, Fuhr D. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet. 2009;373:2234–46.PubMedCrossRef
142.
World Health Organization. Global Action Plan for the Prevention and Control of NCDs 2013-2020. Geneva: World Health Organization; 2013.
143.
World Economic Forum & World Health Organization. From burden to “best buys”: Reducing the economic impact of non-communicable diseases in low- and middle-income countries. Davos: World Economic Forum; 2011.
144.
Rabinovich L, Brutscher PB, de Vries H, Tiessen J, Clift J, Reding A. The affordability of alcoholic beverages in the European Union: Understanding the link between alcohol affordability, consumption and harms. 2009. RAND Europe.
145.
Rehm J, Lachenmeier DW, Jané Llopis E, Imtiaz S, Anderson P. Evidence of reducing ethanol content in beverages to reduce harmful use of alcohol. Lancet Gastroenterol Hepatol. 2016;1:78–83.CrossRef
146.
Rehm J, Shield KD, Rehm MX, Gmel G, Frick U. Modelling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol. 2013;23:89–97.PubMedCrossRef
147.
Purshouse CR, Meier PS, Brennan A, Taylor KB, Rafia R. Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model. Lancet. 2010;375:1355–64.PubMedCrossRef
148.
Holmes J, Meng Y, Meier PS, Brennan A, Angus C, Campbell-Burton A, et al. Effects of minimum unit pricing for alcohol on different income and socioeconomic groups: a modelling study. Lancet. 2014;383:1655–64.PubMedPubMedCentralCrossRef
149.
Health and Safety Executive. Don't mix it: A guide for employers on alcohol at work. United Kingdom: Crown; 1996.
150.
Rehm J, Zatonski W, Taylor B, Anderson P. Epidemiology and alcohol policy in Europe. Addiction. 2011;106:11–9.PubMedCrossRef
151.
152.
Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59:160–8.PubMedCrossRef
153.
Zatonski W, Sulkowska U, Manczuk M, Rehm J, Lowenfels AB, La Vecchia C. Liver cirrhosis mortality in Europe, with special attention to central and eastern Europe. Eur Addict Res. 2010;16:193–201.PubMedCrossRef
154.
Rehm J, Taylor B, Patra J, Gmel G. Avoidable burden of disease: conceptual and methodological issues in substance abuse epidemiology. Int J Methods Psychiatr Res. 2006;15:181–91.PubMedCrossRef
155.
Murray CJL, Lopez A. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet. 1997;349:1436–42.PubMedCrossRef
156.
Ezzati M, Lopez AD, Rodgers AD, Vander Horn S, Murray CJL, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–60.PubMedCrossRef
157.
Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders. Lancet. 2009;373:2223–33.PubMedCrossRef
158.
Lönnroth K, Williams B, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health. 2008;8:289.PubMedPubMedCentralCrossRef
159.
Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction. 2012;107:1246–60.PubMedPubMedCentralCrossRef
Metadata
Title
A narrative review of alcohol consumption as a risk factor for global burden of disease
Authors
Jürgen Rehm
Sameer Imtiaz
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2016
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/s13011-016-0081-2

Other articles of this Issue 1/2016

Substance Abuse Treatment, Prevention, and Policy 1/2016 Go to the issue

Short Report

National doping prevention guidelines: Intent, efficacy and lessons learned - A 4-year evaluation

Research

Psychosocial problems among individuals with substance use disorders in drug rehabilitation centers, Nepal

Research

Alcohol consumption and accentuated personality traits among young adults in Romania: a cross-sectional study

Research

Access to substance use treatment among young adults who use prescription opioids non-medically

Research

The misuse of Cyproheptadine: a non-communicable disease risk behaviour in Kinshasa population, Democratic Republic of Congo

Research

Using the Behavior Change Technique Taxonomy v1 to conceptualize the clinical content of Breaking Free Online: a computer-assisted therapy program for substance use disorders